The Lily Foundation logo featuring a butterfly, hearts and an 'x' for a kiss

Fighting mito,
finding hope.

News

There’s plenty going on in the world of mitochondrial disease, and you can learn all about our work and read the latest news articles and blogs from across all areas of our charity here.

From personal stories about families affected by the disease to the latest research projects and plenty more, why not sign up to our newsletters, and follow us on social media, to ensure you never miss a thing.

Filter by category:

All Articles Support Research Events Personal stories Awareness Fundraising Fitness

Research 6 July 2018

Helping from the heart

A mitochondrial research nurse based at John Radcliffe Hospital in Oxford and funded by The Lily Foundation, Colwynn Phillips represents the best of our charity's fruitful working relationship with the NHS. Here she talks about her dual role supporting affected families and coordinating a patient cohort.

Support 29 June 2018

Lily and the NHS: A partnership worth celebrating

This July the National Health Service turns 70. To celebrate we've put together five key ways in which The Lily Foundation works closely with the NHS to support patients and families affected by mitochondrial disease. It's a unique partnership between a small, specialised charity and one of the world’s largest publicly funded health services, and one that we are immensely proud to uphold.

Research 24 May 2018

Mito conference news

The Lily Foundation recently attended two conferences to hear about the latest developments in mitochondrial research. These were the 11th Annual UK Neuromuscular Translational Research Conference at Fitzwilliam College, Cambridge, and Mitochondrial Medicine 2018 at the Wellcome Genome Campus in Hinxton. Here we share some of the highlights from both events.

Research 18 May 2018

Unlocking NR

Nicotinamide Riboside (NR) is a form of vitamin B3 hyped for its alleged anti-ageing properties, but research shows it could be a treatment for mitochondrial disease. The Lily Foundation has recruited Dr Alex Clout, of UCL's School of Pharmacy and Institute of Neurology, to develop a formulation for patient trials.